Skip to content
Search AI Powered

Latest Stories

PDA raises concern over calls for 'locum blacklist'

The Pharmacists’ Defence Association (PDA) has raised concerns over “a prominent pharmacist’s call to create a sector 'blacklist' for locums regarding disputes over rates.”

A few contractors took it to the Twitter to share screenshots of the messages by locums demanding more pay, which led to the call for ‘blacklisting’ those locums.


“The motivation regarding the current talk of creating a blacklist seems intrinsically tied to hourly rates. Although there are occasional and isolated anecdotal reports on social media of alleged incidents of locums seeking higher rates than already agreed, these are far outstripped by reports of pharmacy businesses unwilling to negotiate and who do not want to pay the necessary rate to engage a locum and instead have set capped or fixed rates,” said the PDA.

It added that all parties should honour agreements they enter into, including a pharmacy’s commitment to the NHS that it will open at set times to provide pharmaceutical services to patients and the public.

The organization reiterated that it will request an investigation by the Competition and Markets Authority if there was evidence to support a finding that two or more pharmacy businesses had colluded together to set a maximum rate they will pay locums. The PDA has revealed that it has got feedback from locums that some 'unrelated pharmacy businesses' in the same area all have the same capped maximum locum rate.

PDA also explained that a “blacklist” requires creating and maintaining a record containing individuals’ data. “The list owner must consider that everyone responsible for using personal data must follow strict rules called ‘data protection principles.”

“It is unclear how those businesses having discussions about creating a blacklist believe the above rules and rights would be met. This includes how a locum would be notified of their inclusion on a list and the reasons that justified it,” the organization noted.

The PDA also stated that the Employment Relations Act 1999 (Blacklisting) Regulations 2010 penalize the listing of trade union members for the purpose of discrimination against them. Under the regulations:

  • It is unlawful for anyone to compile, supply, sell or use a ‘prohibited list’
  • It is unlawful for an employer to refuse employment to a job applicant, to dismiss an employee, or to subject an employee to any other detriment for a reason related to a ‘prohibited list’
  • It is unlawful for an employment agency to refuse to provide its services to an individual for a reason related to a ‘prohibited list’.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
Pharmacies warn against buying unlicensed hay fever treatment Kenalog® online

Kenalog® can cause serious mental health problems.

gettyimages

Don’t buy unlicensed hay fever drug Kenalog® online, pharmacies warn

Patients are being urged to avoid buying unlicensed medications such as Kenalog® online to treat hay fever symptoms this spring, as pharmacists report a sharp rise in public interest in the drug.

The National Pharmacy Association (NPA), which represents over 6000 independent community pharmacies, has warned patients that buying medication from unregulated sellers, such as beauty salons and from social media sites, could serious health risks.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less